BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 8048930)

  • 1. Glucose and insulin responses in isolated human lymphocytes reflect in vivo status: effects of VLCD treatment.
    Tu KY; Matthews R; Topek NH; Matthews KS
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1169-75. PubMed ID: 8048930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
    Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
    Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lactate concentration in obesity and type 2 diabetes.
    Chen YD; Varasteh BB; Reaven GM
    Diabete Metab; 1993; 19(4):348-54. PubMed ID: 8293860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of insulin and energy restriction on the thermic effect of protein in type 2 diabetes mellitus.
    Gougeon R
    Obes Res; 2001 Apr; 9(4):241-50. PubMed ID: 11331427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
    Jazet IM; Pijl H; Frölich M; Romijn JA; Meinders AE
    Metabolism; 2005 Jun; 54(6):705-12. PubMed ID: 15931603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
    Miyashita Y; Koide N; Ohtsuka M; Ozaki H; Itoh Y; Oyama T; Uetake T; Ariga K; Shirai K
    Diabetes Res Clin Pract; 2004 Sep; 65(3):235-41. PubMed ID: 15331203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting the blood glucose lowering effect of a 30-day very low calorie diet in obese Type 2 diabetic patients.
    Jazet IM; Pijl H; Frölich M; Schoemaker RC; Meinders AE
    Diabet Med; 2005 Jan; 22(1):52-5. PubMed ID: 15606691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient.
    Capstick F; Brooks BA; Burns CM; Zilkens RR; Steinbeck KS; Yue DK
    Diabetes Res Clin Pract; 1997 May; 36(2):105-11. PubMed ID: 9229194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of very low calorie diet (VLCD) on body weight, blood glucose and serum lipid metabolism in severe obesity with glucose intolerance.
    Inoue S; Okamura A; Okamoto M; Tanaka K; Sugimasa T; Takamura Y
    Int J Obes; 1989; 13 Suppl 2():183-4. PubMed ID: 2613422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in obese subjects and newly diagnosed NIDDM patients and derangements of pyruvate dehydrogenase in their circulating lymphocytes.
    Curto M; Novi RF; Rabbone I; Maurino M; Piccinini M; Mioletti S; Mostert M; Bruno R; Rinaudo MT
    Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1137-42. PubMed ID: 9426381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between insulin sensitivity and weight reduction in simple obese and obese diabetic patients.
    Ishiguro T; Sato Y; Oshida Y; Yamanouchi K; Okuyama M; Sakamoto N
    Nagoya J Med Sci; 1987 Mar; 49(1-4):61-9. PubMed ID: 3299101
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects.
    Sesti G; D'Alfonso R; Vargas Punti MD; Tullio AN; Liu YY; Federici M; Borboni P; Marini MA; Lauro R; Fusco A
    Diabetologia; 1996 Mar; 39(3):289-95. PubMed ID: 8721774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of VLCD in obese NIDDM (non-insulin dependent diabetes) on glucose, insulin and C-peptide dynamics.
    Weck M; Hanefeld M; Schollberg K
    Int J Obes; 1989; 13 Suppl 2():159-60. PubMed ID: 2693380
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycerol-3-phosphate dehydrogenase activity in human lymphocytes: effects of insulin, obesity and weight loss.
    Tu KY; Ju HS; Pettit F; Shive W; Topek NH; Matthews R; Matthews K
    Biochem Biophys Res Commun; 1995 Feb; 207(1):183-90. PubMed ID: 7857262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the parameters of a compartmental system for the study of the kinetics of plasma glucose and insulin in normal, diabetic, and obese subjects.
    Turco GL; Vercellone G; Pagano PG; Segre G
    J Nucl Biol Med; 1971; 15(1):1-2. PubMed ID: 5127077
    [No Abstract]   [Full Text] [Related]  

  • 17. Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.
    Henry RR; Gumbiner B
    Diabetes Care; 1991 Sep; 14(9):802-23. PubMed ID: 1959474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling blood glucose and insulin kinetics in normal, diabetic and obese subjects.
    Segre G; Turco GL; Vercellone G
    Diabetes; 1973 Feb; 22(2):94-103. PubMed ID: 4687648
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Insulin and plasma inorganic phosphate regulation.
    De Venanzi F
    Acta Physiol Lat Am; 1973; 23(6):633-7. PubMed ID: 4795035
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucose utilization and insulin responsiveness of leucocytes in diabetes.
    KALANT N; SCHUCHER R
    Can J Biochem Physiol; 1962 Jul; 40():899-903. PubMed ID: 14453228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.